Gregor Tuschl - Concepedia

Author

Gregor Tuschl

Merck (Germany)

Also Known As

G Tuschl, G. Tuschl, Gregor Tuschl

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Merck (Germany)Karlsruhe Institute of Technology

About

Gregor Tuschl is an author at Merck (Germany) specializing in liver physiology, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	335
2	Hepatology	3	3	276
3	Biochemistry	2	2	59
4	Cell Biology	2	2	193
5	Cellular Physiology	1	1	100

Gregor Tuschl

Publications

621

Citations

H-Index

Page 1

	Year	Citations
Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor β–induced apoptosis† Patrício Godoy, Jan G. Hengstler, Iryna Ilkavets, Hepatology	2009	233
Effects of cell culture conditions on primary rat hepatocytes—Cell morphology and differential gene expression Gregor Tuschl, Stefan O. Mueller Toxicology Developmental BiologyHepatologyLiver PhysiologyDifferential Gene ExpressionCell Culture	2005	100
Serum-free collagen sandwich cultures of adult rat hepatocytes maintain liver-like properties long term: A valuable model for in vitro toxicity and drug–drug interaction studies Gregor Tuschl, Jens Hrach, Yvonne Walter, Chemico-Biological Interactions Tissue EngineeringDrug–drug Interaction StudiesHepatologyMedicineLiver Physiology	2009	93
Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes Birthe Lauer, Gregor Tuschl, Margret Kling, Chemico-Biological Interactions HepatologyRat HepatocytesMedicineLiver PhysiologyPathology	2008	83
Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes Lysiane Richert, Gregor Tuschl, Catherine Abadie, Toxicology and Applied Pharmacology Mrna ExpressionBiochemistryMedicineLiver PhysiologyBioanalysis	2008	49
Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs) Joel P. Bercu, Melisa Masuda-Herrera, Alejandra Trejo‐Martin, Regulatory Toxicology and Pharmacology	2023	29
Species Differences in the Response of Liver Drug-Metabolizing Enzymes to (S)-4-O-Tolylsulfanyl-2-(4-trifluormethyl-phenoxy)-butyric Acid (EMD 392949) in Vivo and in Vitro Lysiane Richert, Gregor Tuschl, Catherine Viollon‐Abadie, Drug Metabolism and Disposition	2008	24
Species-specific activation of nuclear receptors correlates with the response of liver drug metabolizing enzymes to EMD 392949 in vitro Stefan O. Mueller, Yvonne Fery, Gregor Tuschl, Toxicology Letters Species-specific ActivationBiochemistryMedicineLiver PhysiologyReceptor (Biochemistry)	2009	10

Page 1